SANGAMO THERAPEUTICS, INC. Restricted Cash and Cash Equivalents, Noncurrent
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Restricted Cash and Cash Equivalents, Noncurrent of $0 as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-05-14
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $0.00.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $0.00.
- 2025-09-30: Restricted Cash and Cash Equivalents, Noncurrent $0.00.
- 2025-06-30: Restricted Cash and Cash Equivalents, Noncurrent $1.50M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-05-14 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.50M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.50M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $1.50M 10-Q · filed 2026-05-14 |
| 2024-09-30 | $1.50M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
| 2023-12-31 | $1.50M 10-Q · filed 2025-11-06 |
| 2023-09-30 | $1.50M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $1.50M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $1.50M 10-Q · filed 2024-11-12 |
| 2022-09-30 | $1.50M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $1.50M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $1.50M 10-Q · filed 2023-05-08 |
| 2021-12-31 | $1.50M 10-K · filed 2024-03-13 |
| 2021-09-30 | $1.50M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $1.50M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $1.50M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $1.50M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.50M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $1.50M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $1.50M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $1.50M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.50M 10-Q · filed 2020-11-04 |
| 2019-06-30 | $1.50M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $3.50M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $3.50M 10-K · filed 2021-02-24 |
| 2018-09-30 | $79.94M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $3.50M 10-Q · filed 2019-08-07 |
| 2017-12-31 | $3.50M 10-K · filed 2020-02-28 |